23 January 2020
Visiongain has launched a new pharma report Global Empty Capsules Market Report: Gelatin Capsules, Non-gelatin Capsules, Pig Skin Gelatin, Bovine Derived Gelatin, Bone Meal Gelatin, Hydroxypropyl Methyl Cellulose (HPMC), Pullulan, Starch Material, Antibiotic & Antibacterial Drugs, Vitamins & Dietary Supplements, Cough & Cold Preparations, Anti-inflammatory Drugs, Cardiovascular Drugs, Antacid & Antiflatulent Drugs, Antianemic Drugs, Pharmaceutical Industry, Neutraceutical Industry, Cosmetics Industry, Clinical Research Laboratories.
The empty capsules market is a highly competitive and diverse market with immense potential for growth. The growth drivers of this market are ageing population, increasing applications in the pharmaceutical and nutraceutical industries, increasing demand for non-gelatin/HPMC capsules in nutraceutical industry, and market development in emerging countries due to low manufacturing advantage.
The lead analyst of the report commented "The non-gelatin capsules segment is estimated to grow at the highest CAGR during the forecast period. Strict government regulations, dietary sensitivity of patients, and drug incompatibilities with gelatin capsules are the major factors driving the growth of the non-gelatin capsules segment. the growing demand for non-gelatin-based capsules and the rapidly expanding pharmaceutical industry in emerging countries such as India and China offer significant growth opportunities for players in this market."
Leading companies featured in the report include ACG Worldwide, Bright Pharmacaps Inc., CapsCanada Corporation, Capsugel (Lonza), Healthcaps India Ltd., Medicaps Ltd., Natural Capsules Limited and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.
25 November 2020
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth